Skip to main content

CIO 2023 Posters Main banner

Icon Legend

This session is not in your schedule.

This session is in your schedule. Click again to remove it.

Hepatocellular Carcinoma

Hepatocellular Carcinoma

Type here to filter the list

(1) Four-year Overall Survival from the HIMALAYA Study of Tremelimumab + Durvalumab in Unresectable Hepatocellular Carcinoma

Favorite
(3) Enhancing Treatment of Hepatocellular Carcinoma with Cowpea Mosaic Virus as an Adjuvant Therapy

Favorite
(6) Interventional Oncology Procedures with Adjuvant Adoptive Cell Therapy in the Treatment of Hepatocellular Carcinoma

Favorite
(9) Bowel Complication following Combined (TACE+Y90) Liver Directed Therapy

Favorite
(13) IMbrave050: Phase 3 study of adjuvant atezolizumab + bevacizumab vs surveillance in hepatocellular carcinoma patients

Favorite
(28) Rapid extra segmental metastases of Hepatocellular Carcinoma following Transarterial Chemoembolization: Two Cases

Favorite